Clinical Study
The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India
Table 3
Patient demographics and baseline characteristics.
| Patient characteristics | APD arm | OPD arm |
| Age in years (mean) | 44.70 years | 43.30 years | Sex | | | Male, (%) | 15 (30%) | 15 (30%) | Female, (%) | 35 (70%) | 35 (70%) | Type of cancer | | | Breast cancer | 25 (50%) | 26 (52%) | Lymphoma | 9 (18%) | 7 (14%) | Head and neck cancer | 9 (18%) | 10 (20%) | Osteosarcoma | 5 (10%) | 5 (10%) | Stomach cancer | 2 (4%) | 2 (4%) |
|
|